438 related articles for article (PubMed ID: 33782089)
1. Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.
Crooke PS; Tossberg JT; Porter KP; Aune TM
J Immunol; 2021 Apr; 206(8):1691-1696. PubMed ID: 33782089
[TBL] [Abstract][Full Text] [Related]
2. Adenosine-to-Inosine RNA Editing of Alu Double-Stranded (ds)RNAs Is Markedly Decreased in Multiple Sclerosis and Unedited Alu dsRNAs Are Potent Activators of Proinflammatory Transcriptional Responses.
Tossberg JT; Heinrich RM; Farley VM; Crooke PS; Aune TM
J Immunol; 2020 Nov; 205(10):2606-2617. PubMed ID: 33046502
[TBL] [Abstract][Full Text] [Related]
3. Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection.
Crooke PS; Tossberg JT; Porter KP; Aune TM
Curr Res Immunol; 2021; 2():52-59. PubMed ID: 33969287
[TBL] [Abstract][Full Text] [Related]
4. Alu RNA Structural Features Modulate Immune Cell Activation and A-to-I Editing of Alu RNAs Is Diminished in Human Inflammatory Bowel Disease.
Aune TM; Tossberg JT; Heinrich RM; Porter KP; Crooke PS
Front Immunol; 2022; 13():818023. PubMed ID: 35126398
[TBL] [Abstract][Full Text] [Related]
5. Identification of widespread ultra-edited human RNAs.
Carmi S; Borukhov I; Levanon EY
PLoS Genet; 2011 Oct; 7(10):e1002317. PubMed ID: 22028664
[TBL] [Abstract][Full Text] [Related]
6. Extensive adenosine-to-inosine editing detected in Alu repeats of antisense RNAs reveals scarcity of sense-antisense duplex formation.
Kawahara Y; Nishikura K
FEBS Lett; 2006 Apr; 580(9):2301-5. PubMed ID: 16574103
[TBL] [Abstract][Full Text] [Related]
7. Letter from the editor: Adenosine-to-inosine RNA editing in Alu repeats in the human genome.
Levanon K; Eisenberg E; Rechavi G; Levanon EY
EMBO Rep; 2005 Sep; 6(9):831-5. PubMed ID: 16138094
[TBL] [Abstract][Full Text] [Related]
8. ALU A-to-I RNA Editing: Millions of Sites and Many Open Questions.
Schaffer AA; Levanon EY
Methods Mol Biol; 2021; 2181():149-162. PubMed ID: 32729079
[TBL] [Abstract][Full Text] [Related]
9. Alu elements shape the primate transcriptome by cis-regulation of RNA editing.
Daniel C; Silberberg G; Behm M; Öhman M
Genome Biol; 2014 Feb; 15(2):R28. PubMed ID: 24485196
[TBL] [Abstract][Full Text] [Related]
10. RNA editing underlies genetic risk of common inflammatory diseases.
Li Q; Gloudemans MJ; Geisinger JM; Fan B; Aguet F; Sun T; Ramaswami G; Li YI; Ma JB; Pritchard JK; Montgomery SB; Li JB
Nature; 2022 Aug; 608(7923):569-577. PubMed ID: 35922514
[TBL] [Abstract][Full Text] [Related]
11. One hundred million adenosine-to-inosine RNA editing sites: hearing through the noise.
Ulbricht RJ; Emeson RB
Bioessays; 2014 Aug; 36(8):730-5. PubMed ID: 24889193
[TBL] [Abstract][Full Text] [Related]
12. What do editors do? Understanding the physiological functions of A-to-I RNA editing by adenosine deaminase acting on RNAs.
Heraud-Farlow JE; Walkley CR
Open Biol; 2020 Jul; 10(7):200085. PubMed ID: 32603639
[TBL] [Abstract][Full Text] [Related]
13. Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease.
Vlachogiannis NI; Sachse M; Georgiopoulos G; Zormpas E; Bampatsias D; Delialis D; Bonini F; Galyfos G; Sigala F; Stamatelopoulos K; Gatsiou A; Stellos K
J Mol Cell Cardiol; 2021 Nov; 160():111-120. PubMed ID: 34302813
[TBL] [Abstract][Full Text] [Related]
14. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses.
Tang Q; Rigby RE; Young GR; Hvidt AK; Davis T; Tan TK; Bridgeman A; Townsend AR; Kassiotis G; Rehwinkel J
Immunity; 2021 Sep; 54(9):1961-1975.e5. PubMed ID: 34525337
[TBL] [Abstract][Full Text] [Related]
15. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
16. A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes.
Bazak L; Haviv A; Barak M; Jacob-Hirsch J; Deng P; Zhang R; Isaacs FJ; Rechavi G; Li JB; Eisenberg E; Levanon EY
Genome Res; 2014 Mar; 24(3):365-76. PubMed ID: 24347612
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity.
Roth SH; Levanon EY; Eisenberg E
Nat Methods; 2019 Nov; 16(11):1131-1138. PubMed ID: 31636457
[TBL] [Abstract][Full Text] [Related]
18. Consistent levels of A-to-I RNA editing across individuals in coding sequences and non-conserved Alu repeats.
Greenberger S; Levanon EY; Paz-Yaacov N; Barzilai A; Safran M; Osenberg S; Amariglio N; Rechavi G; Eisenberg E
BMC Genomics; 2010 Oct; 11():608. PubMed ID: 21029430
[TBL] [Abstract][Full Text] [Related]
19. ADAR regulates APOL1 via A-to-I RNA editing by inhibition of MDA5 activation in a paradoxical biological circuit.
Riella CV; McNulty M; Ribas GT; Tattersfield CF; Perez-Gill C; Eichinger F; Kelly J; Chun J; Subramanian B; Guizelini D; ; Alper SL; Pollak MR; Sampson MG; Friedman DJ
Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2210150119. PubMed ID: 36282916
[No Abstract] [Full Text] [Related]
20. Altered RNA Editing in Atopic Dermatitis Highlights the Role of Double-Stranded RNA for Immune Surveillance.
Karmon M; Kopel E; Barzilai A; Geva P; Eisenberg E; Levanon EY; Greenberger S
J Invest Dermatol; 2023 Jun; 143(6):933-943.e8. PubMed ID: 36502941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
